Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FADD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 191 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wu, L; Strasser, A
      "Decisions, decisions ...": beta-catenin-mediated activation of TCF-I and Lef-I influences the fate of developing T cells

      NATURE IMMUNOLOGY
    2. Miyazaki, T; Reed, JC
      A GTP-binding adaptor protein couples TRAIL receptors to apoptosis-inducing proteins

      NATURE IMMUNOLOGY
    3. Los, M; Stroh, C; Janicke, RU; Engels, IH; Schulze-Osthoff, K
      Caspases: more than just killers?

      TRENDS IN IMMUNOLOGY
    4. Daigle, I; Simon, HU
      Alternative functions for TRAIL receptors in eosinophils and neutrophils

      SWISS MEDICAL WEEKLY
    5. Frank, S; Ebert, AD
      License to kill tumors: How much hope is justified for trail?

      CURRENT PHARMACEUTICAL DESIGN
    6. Nagane, M; Huang, HJS; Cavenee, WK
      The potential of TRAIL for cancer chemotherapy

      APOPTOSIS
    7. Moshnikova, AB; Moshnikov, SA; Afanasyev, VN; Krotova, KE; Sadovnikov, VB; Beletsky, IP
      Cell death induced by chemical homobifunctional cross-linkers - Cross-linker induced apoptosis

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    8. Mitsiades, N; Mitsiades, CS; Poulaki, V; Anderson, KC; Treon, SP
      Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Morgan, MJ; Thorburn, J; Thomas, L; Maxwell, T; Brothman, AR; Thorburn, A
      An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells

      CELL DEATH AND DIFFERENTIATION
    10. Sarker, M; Ruiz-Ruiz, C; Lopez-Rivas, A
      Activation of protein kinase C inhibits TRAIL-induced caspases activation,mitochondrial events and apoptosis in a human leukemic T cell line

      CELL DEATH AND DIFFERENTIATION
    11. Beresford, SA; Davies, MA; Gallick, GE; Donato, NJ
      Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    12. Ichikawa, K; Liu, WM; Zhao, LM; Wang, Z; Liu, D; Ohtsuka, T; Zhang, HG; Mountz, JD; Koopman, WJ; Kimberly, RP; Zhou, T
      Tumoricidal activity of a novel anti-human DR5 monoclonal antibody withouthepatocyte cytotoxicity

      NATURE MEDICINE
    13. Zelent, A
      Hot on the TRAIL of acute promyelocytic leukemia

      NATURE MEDICINE
    14. Suzuki, A; Obata, S; Hayashida, M; Kawano, H; Nakano, T; Shiraki, K
      SADS: A new component of Fas-DISC is the accelerator for cell death signaling and is downregulated in patients with colon carcinoma

      NATURE MEDICINE
    15. Ding, HF; Fisher, DE
      P53, caspase 8, and regulation of apoptosis after ionizing radiation

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    16. Chen, CY; Juo, P; Liou, JS; Li, CQ; Yu, Q; Blenis, J; Faller, DV
      The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis

      CELL GROWTH & DIFFERENTIATION
    17. Oshima, K; Yanase, N; Ibukiyama, C; Yamashina, A; Kayagaki, N; Yagita, H; Mizuguchi, J
      Involvement of trail/trail-R interaction in IFN-alpha-induced apoptosis ofdaudi B lymphoma cells

      CYTOKINE
    18. Li, LY; Shu, HB
      Molecular mechanisms of TRAIL-induced apoptosis of cancer cells

      CHINESE SCIENCE BULLETIN
    19. Newton, K; Kurts, C; Harris, AW; Strasser, A
      Effects of a dominant interfering mutant of FADD on signal transduction inactivated T cells

      CURRENT BIOLOGY
    20. Kasof, GM; Lu, JJ; Liu, DR; Speer, B; Mongan, KN; Gomes, BC; Lorenzi, MV
      Tumor necrosis factor-alpha induces the expression of DR6, a member of theTNF receptor family, through activation of NF-kappa B

      ONCOGENE
    21. Toomey, NL; Deyev, VV; Wood, C; Boise, LH; Scott, D; Liu, LH; Cabral, L; Podack, ER; Barber, GN; Harrington, WJ
      Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphoma

      ONCOGENE
    22. Fukazawa, T; Fujiwara, T; Uno, F; Teraishi, F; Kadowaki, Y; Itoshima, T; Takata, Y; Kagawa, S; Roth, JA; Tschopp, J; Tanaka, N
      Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells

      ONCOGENE
    23. Liu, BL; Fan, Z
      The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway

      ONCOGENE
    24. Suliman, A; Lam, A; Datta, R; Srivastava, RK
      Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

      ONCOGENE
    25. Belka, C; Schmid, B; Marini, P; Durand, E; Rudner, J; Faltin, H; Bamberg, M; Schulze-Osthoff, K; Budach, W
      Sensitization of resistant lymphoma cells to irradiation-induced apoptosisby the death ligand TRAIL

      ONCOGENE
    26. Shao, RG; Cao, CX; Nieves-Neira, W; Dimanche-Boitrel, MT; Solary, E; Pommier, Y
      Activation of the Fas pathway independently of Fas ligand during apoptosisinduced by camptothecin in p53 mutant human colon carcinoma cells

      ONCOGENE
    27. Teitz, T; Lahti, JM; Kidd, VJ
      Aggressive childhood neuroblastomas do not express caspase-8: an importantcomponent of programmed cell death

      JOURNAL OF MOLECULAR MEDICINE-JMM
    28. Jin, KL; Graham, TH; Mao, XO; Nagayama, T; Simon, RP; Greenberg, DA
      Fas (CD95) may mediate delayed cell death in hippocampal CA1 sector after global cerebral ischemia

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    29. Gores, GJ; Kaufmann, SH
      Is TRAIL hepatotoxic?

      HEPATOLOGY
    30. Koga, S; Hirohata, S; Kondo, Y; Komata, T; Takakura, M; Inoue, M; Kyo, S; Kondo, S
      FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo

      ANTICANCER RESEARCH
    31. Donahue, CJ; Santoro, M; Hupe, D; Jones, JM; Pollok, B; Heim, R; Giegel, D
      Correlating cell cycle with apoptosis in a cell line expressing a tandem green fluorescent protein substrate specific for group II caspases

      CYTOMETRY
    32. Chan, FKM; Siegel, RM; Zacharias, D; Swofford, R; Holmes, KL; Tsien, RY; Lenardo, MJ
      Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein

      CYTOMETRY
    33. Jayanthi, S; Lewis, BD; Cadet, JL
      Fas-induced apoptosis of glioma cells is associated with down-regulation of the hSCO1 protein, a subunit of complex IV

      MOLECULAR BRAIN RESEARCH
    34. Morsczeck, C; Berger, S; Plum, G
      The macrophage-induced gene (mig) of Mycobacterium avium encodes a medium-chain acyl-coenzyme A synthetase

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    35. Shisler, JL; Moss, B
      Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein

      VIROLOGY
    36. Rosenthal, DS; Simbulan-Rosenthal, CMG; Liu, WF; Stoica, BA; Smulson, ME
      Mechanisms of JP-8 jet fuel cell toxicity. II. Induction of necrosis in skin fibroblasts and keratinocytes and modulation of levels of Bcl-2 family members

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    37. Wang, L; Chun, HJ; Wong, W; Spencer, DM; Lenardo, MJ
      Caspase-10 is an initiator caspase in death receptor signaling

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    38. Baetu, TM; Kwon, H; Sharma, S; Grandvaux, N; Hiscott, J
      Disruption of NF-kappa B signaling reveals a novel role for NF-kappa B in the regulation of TNF-related apoptosis-inducing ligand expression

      JOURNAL OF IMMUNOLOGY
    39. Inada, H; Izawa, I; Nishizawa, M; Fujita, E; Kiyono, T; Takahashi, T; Momoi, T; Inagaki, M
      Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD

      JOURNAL OF CELL BIOLOGY
    40. Benedict, CA; Norris, PS; Prigozy, TI; Bodmer, JL; Mahr, JA; Garnett, CT; Martinon, F; Tschopp, J; Gooding, LR; Ware, CF
      Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and-2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Kischkel, FC; Lawrence, DA; Tinel, A; LeBlanc, H; Virmani, A; Schow, P; Gazdar, A; Blenis, J; Arnott, D; Ashkenazi, A
      Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Han, ZY; Pantazis, P; Wyche, JH; Kouttab, N; Kidd, VJ; Hendrickson, EA
      A Fas-associated Death Domain Protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line

      JOURNAL OF BIOLOGICAL CHEMISTRY
    43. Burns, TF; El-Deiry, WS
      Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Harper, N; Farrow, SN; Kaptein, A; Cohen, GM; MacFarlane, M
      Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Siegmund, D; Mauri, D; Peters, N; Juo, P; Thome, M; Reichwein, M; Blenis, J; Scheurich, P; Tschopp, J; Wajant, H
      Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    46. Zheng, LX; Schickling, O; Peter, ME; Lenardo, MJ
      The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm

      JOURNAL OF BIOLOGICAL CHEMISTRY
    47. Zhang, J; Kabra, NH; Cado, D; Kang, C; Winoto, A
      FADD-deficient T cells exhibit a disaccord in regulation of the cell cyclemachinery

      JOURNAL OF BIOLOGICAL CHEMISTRY
    48. Jin, YJ; Atkinson, SJ; Marrs, JA; Gallagher, PJ
      Myosin II light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    49. Krueger, A; Schmitz, I; Baumann, S; Krammer, PH; Kirchhoff, S
      Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

      JOURNAL OF BIOLOGICAL CHEMISTRY
    50. Varela, N; Munoz-Pinedo, C; Ruiz-Ruiz, C; Robledo, G; Pedroso, M; Lopez-Rivas, A
      Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism

      JOURNAL OF BIOLOGICAL CHEMISTRY
    51. Tran, SEF; Holmstrom, TH; Ahonen, M; Kahari, VM; Eriksson, JE
      MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. McDonald, ER; Chui, PC; Martelli, PF; Dicker, DT; El-Deiry, WS
      Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling

      JOURNAL OF BIOLOGICAL CHEMISTRY
    53. Nesterov, A; Lu, XJ; Johnson, M; Miller, GJ; Ivashchenko, Y; Kraft, AS
      Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    54. Bi, BY; Littlewood, NK; Crispe, IN
      Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes

      IMMUNOLOGY
    55. Migita, K; Yamasaki, S; Kita, M; Ida, H; Shibatomi, K; Kawakami, A; Aoyagi, T; Eguchi, K
      Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3

      IMMUNOLOGY
    56. Park, WS; Lee, JH; Shin, MS; Park, JY; Kim, HS; Kim, YS; Park, CH; Lee, SK; Lee, SH; Lee, SN; Kim, H; Yoo, NJ; Lee, JY
      Inactivating mutations of KILLER/DR5 gene in gastric cancers

      GASTROENTEROLOGY
    57. Kamata, K; Okamoto, S; Oka, S; Kamata, H; Yagisawa, H; Hirata, H
      Cycloprodigiosin hydrocloride suppresses tumor necrosis factor (TNF) alpha-induced transcriptional activation by NF-kappa B

      FEBS LETTERS
    58. Weber, CH; Vincenz, C
      A docking model of key components of the DISC complex: death domain superfamily interactions redefined

      FEBS LETTERS
    59. Meng, RD; El-Deiry, WS
      p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma

      EXPERIMENTAL CELL RESEARCH
    60. Mitsiades, N; Poulaki, V; Mitsiades, C; Tsokos, M
      Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5

      CANCER RESEARCH
    61. Lacour, S; Hammann, A; Wotawa, A; Corcos, L; Solary, E; Dimanche-Boitrel, MT
      Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis

      CANCER RESEARCH
    62. Seol, DW; Li, JR; Seol, MH; Park, SY; Talanian, RV; Billiar, TR
      Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): Caspase-8 is required for TRAIL-induced apoptosis

      CANCER RESEARCH
    63. Nishimura, S; Adachi, M; Ishida, T; Matsunaga, T; Uchida, H; Hamada, H; Imai, K
      Adenovirus-mediated transfection of caspase-8 augments anoikis and inhibits peritoneal dissemination of human gastric carcinoma cells

      CANCER RESEARCH
    64. Chakraborty, M; Qiu, SGF; Vasudevan, KM; Rangnekar, VM
      Par-4 drives trafficking and activation of Fas and FasL to induce prostatecancer cell apoptosis and tumor regression

      CANCER RESEARCH
    65. Huang, Y; He, Q; Hillman, MJ; Rong, R; Sheikh, MS
      Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells

      CANCER RESEARCH
    66. Fiumara, P; Younes, A
      CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (APO-2L) in haematological malignancies

      BRITISH JOURNAL OF HAEMATOLOGY
    67. Hofmann, WK; de Vos, S; Tsukasaki, K; Wachsman, W; Pinkus, GS; Said, JW; Koeffler, HP
      Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray

      BLOOD
    68. Mitsiades, CS; Treon, SP; Mitsiades, N; Shima, Y; Richardson, P; Schlossman, R; Hideshima, T; Anderson, KC
      TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

      BLOOD
    69. Kim, K
      Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    70. Nagy, B; Yeh, WC; Mak, TW; Chiu, SM; Separovic, D
      FADD null mouse embryonic fibroblasts undergo apoptosis after photosensitization with the silicon phthalocyanine Pc 4

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    71. Meng, RD; McDonald, ER; Sheikh, MS; Fornace, AJ; El-Deiry, WS
      The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis

      MOLECULAR THERAPY
    72. Hueber, AO
      CD95: more than just a death factor?

      NATURE CELL BIOLOGY
    73. Okamoto, K; Kobayashi, T; Kobata, T; Hasunuma, T; Kato, T; Sumida, T; Nishioka, K
      Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes

      RHEUMATOLOGY
    74. Shearwin-Whyatt, LM; Harvey, NL; Kumar, S
      Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD

      CELL DEATH AND DIFFERENTIATION
    75. Kim, KH; Fisher, MJ; Xu, SQ; El-Deiry, WS
      Molecular determinants of response to TRAIL in killing of normal and cancer cells

      CLINICAL CANCER RESEARCH
    76. Sprick, MR; Weigand, MA; Rieser, E; Rauch, CT; Juo, P; Blenis, J; Krammer, PH; Walczak, H
      FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

      IMMUNITY
    77. Harrington, JR
      SODD-silencer of death domains

      STEM CELLS
    78. Palazzo, FF; Hammond, LJ; Goode, AW; Mirakian, R
      Death of the autoimmune thyrocyte: Is it pushed or does it jump?

      THYROID
    79. Ryu, HS; Chang, KH; Chang, SJ; Kim, MS; Joo, HJ; Oh, KS
      Expression ol TRAIL (TNF-related apoptosis-inducing Ligand) receptors in cervical cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    80. Ryu, SW; Kim, HS; Yoon, SK; Murty, VVVS; Kim, E
      Human Fas associated factor 1, hFAF1, gene maps to chromosome band 1p32

      MOLECULES AND CELLS
    81. Felderhoff-Mueser, U; Taylor, DL; Greenwood, K; Kozma, M; Stibenz, D; Joashi, UC; Edwards, AD; Mehmet, H
      Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injuryto the developing rat brain

      BRAIN PATHOLOGY
    82. Yoshida, T; Higuchi, T; Hagiyama, H; Strasser, A; Nishioka, K; Tsubata, T
      Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice

      INTERNATIONAL IMMUNOLOGY
    83. Chaudhary, PM; Eby, MT; Jasmin, A; Kumar, A; Liu, L; Hood, L
      Activation of the NF-kappa B pathway by Caspase 8 and its homologs

      ONCOGENE
    84. Herr, I; Posovszky, C; Di Marzio, L; Cifone, MG; Boehler, T; Debatin, KM
      Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha

      ONCOGENE
    85. Gil, J; Esteban, M
      The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors

      ONCOGENE
    86. OhYama, T; Tsukumo, S; Yajima, N; Sakamaki, K; Yonehara, S
      Reduction of thymocyte numbers in transgenic mice expressing viral FLICE-inhibitory protein in a Fas-independent manner

      MICROBIOLOGY AND IMMUNOLOGY
    87. Yamanaka, T; Shiraki, K; Sugimoto, K; Ito, T; Fujikawa, K; Ito, M; Takase, K; Moriyama, M; Nakano, T; Suzuki, A
      Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

      HEPATOLOGY
    88. Lin, Y; Devin, A; Cook, A; Keane, MM; Kelliher, M; Lipkowitz, S; Liu, ZG
      The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of I kappa B kinase and c-Jun N-terminal kinase

      MOLECULAR AND CELLULAR BIOLOGY
    89. Gibson, SB; Oyer, R; Spalding, AC; Anderson, SM; Johnson, GL
      Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

      MOLECULAR AND CELLULAR BIOLOGY
    90. Newton, K; Harris, AW; Strasser, A
      FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor

      EMBO JOURNAL
    91. Pawlowski, JE; Nesterov, A; Scheinman, RI; Johnson, TR; Kraft, AS
      NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL)

      ANTICANCER RESEARCH
    92. Keane, MM; Rubinstein, Y; Cuello, M; Ettenberg, SA; Banerjee, P; Nau, MM; Lipkowitz, S
      Inhibition of NF-kappa B activity enhances TRAIL mediated apoptosis in breast cancer cell lines

      BREAST CANCER RESEARCH AND TREATMENT
    93. Wang, TTY; Jeng, JJ
      Coordinated regulation of two TRAIL-R2/KILLER/DR5 mRNA isoforms by DNA damaging agents, serum and 17 beta-estradiol in human breast cancer cells

      BREAST CANCER RESEARCH AND TREATMENT
    94. Rothstein, TL; Zhong, XM; Schram, BR; Negm, RS; Donohoe, TJ; Cabral, DS; Foote, LC; Schneider, TJ
      Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule

      IMMUNOLOGICAL REVIEWS
    95. Choi, YJ; Baranowska-Daca, E; Nguyen, V; Koji, T; Ballantyne, CM; Sheikh-Hamad, D; Suki, WN; Truong, LD
      Mechanism of chronic obstructive uropathy: Increased expression of apoptosis-promoting molecules

      KIDNEY INTERNATIONAL
    96. Strasser, A; O'Connor, L; Dixit, VM
      Apoptosis signaling

      ANNUAL REVIEW OF BIOCHEMISTRY
    97. Wu, GS; Kim, K; El-Deiry, WS
      Killer/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death

      CANCER GENE THERAPY
    98. Murakami-Mori, K; Mori, S; Bonavida, B
      Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: Growth and apoptosis

      ADVANCES IN CANCER RESEARCH, VOL 78
    99. Balachandran, S; Roberts, PC; Kipperman, T; Bhalla, KN; Compans, RW; Archer, DR; Barber, GN
      Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway

      JOURNAL OF VIROLOGY
    100. Ahmad, N; Gupta, S; Feyes, DK; Mukhtar, H
      Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells

      JOURNAL OF INVESTIGATIVE DERMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 20:45:03